This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| AstraZeneca | Bernstein ups TP to 3617p from 3595p, market-perform |
| AstraZeneca | SocGen ups TP to 3,126p from 3,030p, sell |
| Beazley | Espirito Santo Investment Bank ups fair value to 283p from 260p, neutral |
| Greene King | Nomura ups TP to 846p from 585p, neutral |
| IMI | Berenberg cuts TP to 1,500P from 1,600P, Hold |
| Johnson Matthey | JP Morgan cuts TP to 3,900p from 4,040p, overweight |
| Marston’s | Nomura downgrades to neutral from Buy; ups TP to 143p from 116p |
| Mitchells & Butlers | Nomura ups to Buy from neutral; TP to 540P from 390P |
| Rotork | Berenberg ups to Buy from Hold rating |
| Shire | Cowen and Co ups TP to $165 from $145, outperform |
| Tate & Lyle | JP Morgan ups to overweight from underweight; TP to 900p from 735p |
| Weir Group | Berenberg cuts TP to 2,570P from 2,675P, Buy |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research